Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RPID Hot Sheet
Join SI Premium – FREE
Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q4 EPS of ($0.22), $0.01 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.8 million.
GUIDANCE:
Rapid Micro Biosystems, Inc. sees FY2025 revenue of ~$32 million, versus the consensus of $32.9 million.
For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evergy (EVRG) Tops Q3 EPS by 38c
- Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q3 EPS
- Shift4 Payments (FOUR) Tops Q3 EPS by 12c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
